Soleno Therapeutics (SLNO) P/E (2014 - 2026)
Soleno Therapeutics (SLNO) P/E from Dec 31, 2014 to May 19, 2026. The TTM Soleno Therapeutics (SLNO) P/E is 29.02. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Soleno Therapeutics (SLNO)
| Year | P/E | Change |
|---|---|---|
| 2026 | 29.02 | -80.06% |
| 2025 | 145.48 | -1492.66% |
| 2024 | -10.45 | -13.70% |
| 2023 | -12.11 | +1633.65% |
| 2022 | -0.70 | -34.04% |
| 2021 | -1.06 | -83.48% |
| 2020 | -6.41 | -63.60% |
| 2019 | -17.60 | +89.47% |
| 2018 | -9.29 | +144.68% |
| 2017 | -3.80 | -24.32% |
| 2016 | -5.02 | -3.12% |
| 2015 | -5.18 | -25.97% |
| 2014 | -7.00 | N/A |
Comparison Soleno Therapeutics (SLNO) P/E with competitors
Soleno Therapeutics (SLNO) P/E is 29.02.